![]() This discussion will include consideration of the vaccine composition for fall to winter, 2023-2024. The committee will discuss and make recommendations on the selection of strain(s) to be included in the periodic updated COVID-19 vaccines for the 2023-2024 vaccination campaign. Vaccines and Related Biological Products Advisory Committee The FDA has advised manufacturers seeking to update their COVID-19 vaccines that they should develop vaccines with a monovalent XBB.1.5 composition. The FDA posted information regarding the formula for COVID-19 vaccines for the 2023-2024 fall and winter seasons. Updated COVID-19 Vaccines for Use in the United States Beginning in Fall 2023 Today’s actions relate to the updated mRNA vaccines for 2023-2024 made by Moderna and Pfizer-BioNTech. Food and Drug Administration took action on updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against the most serious outcomes, including hospitalization and death.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |